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doi:10.1Objective: Total aortic arch replacement typically requires hypothermic circulatory arrest, carrying risks of ce-
rebral ischemia. We recently introduced left carotid–subclavian bypass before total aortic arch replacement with
thoracic stent grafting to achieve hybrid arch reconstruction with short periods of selective antegrade cerebral per-
fusion.
Methods: From 2004 to 2009, 332 patients underwent ascending aorta or arch replacements. Of these, 37 under-
went total aortic arch replacement. In 2008, we began performing left carotid–subclavian bypass before subtotal
arch replacement, with side-graft anastomoses to innominate and left carotid arteries. Patients then underwent aor-
tic graft stent deployment to complete arch reconstruction. Twenty-eight patients underwent conventional arch
replacement (group I); 9 underwent hybrid arch replacement (group II).
Results: Selective antegrade cerebral perfusion time in group I was 33.3  13.7 minutes versus 18.9  9.2 min-
utes in group II (P¼ .007). Among group I patients, 82% required hypothermic circulatory arrest (vs 0% in group
II, P< .001). Mean cardiopulmonary bypass and aortic crossclamp times were longer in group I than group II
(P<.05). Incidence of neurologic complications was 14% in group I (4/28) versus 0% (0/9) in group II, although
this finding did not reach statistical significance (P ¼ .55).
Conclusions: Left carotid–subclavian bypass before arch replacement with staged thoracic stent grafting to
achieve hybrid arch reconstruction was associated with decreased selective antegrade cerebral perfusion, cardiopul-
monary bypass, and aortic crossclamp times and eliminated hypothermic circulatory arrest. This technique may
minimize neurologic complications associated with arch replacement and provide a viable hybrid approach to pa-
tients with arch aneurysms and dissections. (J Thorac Cardiovasc Surg 2010;139:717-22)E
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SConventional approaches to total aortic arch replacement
(TAAR) typically require either a period of hypothermic cir-
culatory arrest (HCA), the use of selective antegrade cere-
bral perfusion (SACP), or both, carrying risks of cerebral
and spinal cord ischemia. In addition, extensive arch and
thoracic aneurysms generally involve complex, staged oper-
ations that carry substantial perioperative mortality risk, as
well as significant risks of aneurysmal rupture between the
staged operative interventions.1,2 As a result, hybrid arch re-
pairs have been introduced that use open subtotal aortic arch
replacements combined with concomitant or staged thoracic
endovascular aneurysm repair (TEVAR) in attempts to
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The Journal of Thoracic and CaOur goals in designing a hybrid arch repair included the
following: (1) elimination of the use of HCA during the
open repair and of a second, complex open surgical proce-
dure; (2) compatibility with root procedures that are fre-
quently required in this patient group, such as ‘‘bioroots’’
or valve-sparing root procedures; (3) simplification of the
TEVAR approach to make it feasible and easily reproduc-
ible; and (4) elimination of the left subclavian–graft anasto-
mosis, because it is most difficult to visualize adequately
through a median sternotomy. To this end, we recently intro-
duced the use of left carotid–subclavian arterial bypass
(CSB) before TAAR with staged thoracic stent grafting to
achieve a hybrid total arch reconstruction with relatively
short periods of SACP and without the need for HCA or
a second open surgical procedure. The aortic graft serves
as a relatively long proximal landing zone that makes the
TEVAR procedure relatively straightforward and reproduc-
ible. For the purposes of this study, we compared our insti-
tutional experiences with conventional and hybrid TAAR.MATERIALS AND METHODS
Patient Selection
A retrospective review of all aortic procedures performed at Columbia
Presbyterian Medical Center, New York, from January 1, 2004, to May 1,rdiovascular Surgery c Volume 139, Number 3 717
FIGURE 1. Photograph depicting example of custom-made Dacron poly-
ester fabric graft (Terumo Cardiovascular Systems, Ann Arbor, Mich) cur-
rently being used for hybrid total arch reconstruction. Labels denote graft
orientations of proximal and distal ends, as well as side arms for the innom-
inate and left carotid anastomoses. There is additional 9-mm side arm for
access with concomitant thoracic endovascular aneurysm repair. This is per-
formed in an antegrade fashion into the distal end of the graft to complete the
total arch reconstruction. If staged thoracic endovascular aneurysm repair is
performed endovascularly, radiopaque markers aid in this transfemoral
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
CSB ¼ carotid–subclavian arterial bypass
HCA ¼ hypothermic circulatory arrest
SACP ¼ selective antegrade cerebral perfusion
TAAR ¼ total aortic arch replacement
TEVAR ¼ thoracic endovascular aneurysm repair
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S2009, was conducted. A total of 332 patients underwent aortic procedures
during this period at our institution. Of these, 37 patients underwent
TAAR, and these patients were the focus of our study. The indication for
TAAR was an arch aneurysm with or without type A aortic dissection.
The study was approved by the local institutional review board, and require-
ments for informed consent were waived.
Of the 37 patients who had undergone TAAR, 28 patients had undergone
conventional repair with right axillary artery cannulation and use of HCA
with periods of SACP. These patients comprised group I. Starting in January
2008, we began using a hybrid approach for TAAR without the use of HCA.
This technique, which is described in detail in the Operative Technique sec-
tion, involves the use of right axillary cannulation, a subtotal aortic arch
replacement with side grafts to the innominate and left carotid arteries,
left CSB, and either concomitant or staged thoracic aortic stent grafting to
complete the TAAR. The 9 consecutive patients who underwent hybrid
repair comprise group II.approach, marking the most proximal margin of proximal landing zone.Operative Technique
All operations were done through median sternotomy. Cardiopulmonary
bypass (CPB) was established by cannulation of the right axillary artery and
right atrium, as previously described.7 Briefly, the right axillary cannulation
technique involved sewing an 8-mm Dacron polyester fabric graft end-to-
side to the axillary artery with 6-0 monofilament suture. A 24F end-hole
wire-wrapped aortic cannula was then passed through the graft and secured
in place with silk ties. Systemic hypothermia with a target temperature of 28
C was used for group II patients, for whom SACP was used without the use
of HCA. Group I patients were cooled to a target temperature of 18 C to
meet the requirements for HCA and periods of SACP. Antegrade and retro-
grade blood cardioplegic doses were given initially, with repeat cardioplegic
doses typically given at 20-minute intervals in a retrograde fashion.
Group I patients underwent conventional TAAR. A Hemashield aortic
graft with separate side arms for the 3 arch vessels (Maquet Cardiovascular,
San Jose, Calif) was used. Anastomoses between the graft and the distal
aorta and between the graft and the left subclavian and left carotid arteries
were performed in sequence under HCA. The innominate anastomosis
was typically performed under SACP whenever technically feasible. CPB
was then resumed with a clamp on the graft proximal to the head vessels.
The proximal aorta–graft anastomosis and any concomitant proximal proce-
dures (eg, valve-sparing aortic root reconstructions, root replacement) were
then completed during rewarming.
Group II patients underwent a hybrid arch repair. These patients first un-
derwent a left CSB (in the same operating room session) through a standard
left supraclavicular incision. The right axillary artery graft was then sewn
and the graft cannulated. We have designed a custom-made Dacron polyes-
ter fabric aortic graft (Terumo Cardiovascular Systems, Ann Arbor, Mich),
although such a construct can be fashioned with generic grafts on the back
table (Figure 1). These grafts ranged from 28 to 32 mm in size. Before ini-
tiation of CPB, the left carotid artery was clamped and divided. During this
period, carotid flow was temporarily maintained by the left CSB flow. We
performed the graft to left carotid anastomosis and subsequently clamped
this sidearm of the graft. We then initiated CPB and crossclamped the aorta.718 The Journal of Thoracic and Cardiovascular SurgAfter the target temperature of 28 C was reached, we transitioned to SACP
by clamping the innominate artery to perform the anastomoses of the distal
graft to the aorta and the graft to the innominate artery. We subsequently
clamped the graft proximally and reinstituted full CPB. During the rewarm-
ing phase, we performed our proximal anastomosis and completed any root
or valve-sparing procedures. We have found that visualization for concom-
itant root replacement is made technically easier by transecting our graft in 2
pieces and then performing a graft–graft anastomosis. In these group II
patients, the left subclavian artery was divided with an endovascular stapler
before closure of the sternotomy to avoid competitive flow to the left sub-
clavian artery through the left CSB. Figure 2 is an illustration of the
completed open subtotal aortic arch replacement with side grafts to the
cerebral vessels used in our group II patients.
The hybrid arch repair was completed with either concomitant (n¼ 2) or
staged (n ¼ 7) TEVAR with thoracic stent graft deployment directly into
our aortic graft, which was used as our proximal landing zone. A proximal
landing zone at least 2 cm in length was created with the custom aortic graft,
although the landing zone was typically much longer than 2 cm. Approxi-
mately 10% oversizing was used with the stent graft relative to the aortic
graft size. That is, 28-mm aortic grafts were treated with a size 31-mm
GORE-TAG stent device (W. L. Gore & Associates, Inc, Flagstaff, Ariz),
30-mm aortic grafts with a size 34-mm GORE-TAG device, and 32-mm
aortic grafts with a 37-mm GORE-TAG device.
A 9-mm sidearm (Figure 1) allowed antegrade deployment of the stent
graft intraoperatively as part of concomitant TEVAR. In these cases, we
elected to deploy the GORE-TAG stent without the sheath, which allowed
us to use the 9-mm sidearm. The sidearm was placed adjacent to grafts for
the cerebral vessels to avoid kinking of the graft during placement of the
stent. If the sheath were to be used during antegrade deployment, a larger
sidearm graft (at least 10 mm) would be required, and the graft could be
placed more proximally on the aortic graft to permit easier handling of
the sheath. The sidearm was ligated after deployment of the stent. In stagedery c March 2010
FIGURE 2. Illustration depicting completed open repair in the group II
patients. Approach involves starting with left carotid subclavian bypass.
Graft–left carotid anastomosis is performed off cardiopulmonary bypass
after clamping of left carotid artery. During this time, blood supply is
temporarily provided through left subclavian–left carotid flow. Subse-
quently, selective antegrade cerebral perfusion is instituted for graft–in-
nominate artery and distal aortic anastomoses. Proximal graft is then
clamped, and full cardiopulmonary flow reinstituted. Proximal anastomo-
sis is completed during rewarming. Left subclavian artery is typically li-
gated at end of procedure through sternotomy to avoid competitive flow
with left carotid–subclavian arterial bypass. Thoracic endograft is used to
complete arch replacement, with distal aortic graft as proximal landing
zone.
TABLE 1. Preoperative study group characteristics
Group I
(n ¼ 28)
Group II
(n ¼ 9) P value
Age (y, mean  SD) 64.7  15.0 63.0  18.7 .78
Male (No.) 17 (61%) 5 (56%) >.99
Diabetes mellitus (No.) 5 (18%) 1 (11%) >.999
Renal insufficiency (No.) 8 (29%) 1 (11%) .40
Chronic obstructive
pulmonary disease (No.)
6 (21%) 1 (11%) .66
Reoperative surgery (No.) 10 (36%) 3 (33%) >.999
Type A or B dissection (No.) 18 (64%) 3 (33%) .14
Aneurysm size (cm,
mean  SD)
6.4  1.6 5.7  1.3 .23
Fisher’s Exact Test (2-sided) was used for categoric variables and independent t test
(2-sided) was used for continuous variables.
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STEVAR cases, the stent was placed through a 24F sheath positioned in the
femoral artery, and radiopaque markers on the custom aortic graft simplified
the precise positioning for deployment. The decision to perform the TEVAR
in a staged or concomitant manner was made by the attending surgeon on
clinical grounds.
Staged TEVAR was performed through the common femoral artery
on postoperative day 3 to 7 at a clinically convenient time. Lumbar
drain placement was performed routinely for all patients undergoing
staged TEVAR. A 22F or 24F sheath was placed into the femoral
artery. A standard pigtail catheter was used to help determine appropri-
ate stent graft lengths. A GORE-TAG stent device was advanced
through the sheath and into the aortic graft with the guidance of radi-
opaque markers as the margin of the proximal landing zone (Figure 1).
The stent graft was deployed and then dilated with a GORE trilobed
balloon (W. L. Gore) proximally and distally. Arch angiography was
performed to confirm positioning of the stent graft and successful exclu-
sion of the aneurysm. Additional stent grafts were placed if necessary.
The femoral artery cannulation site was closed with a PROSTAR suture
closure device (n ¼ 3; Abbott Laboratories, Abbott Park, Ill) or by
direct surgical repair (n ¼ 4).The Journal of Thoracic and CaPostoperative Care and Follow-up
The postoperative course and complications related to surgery were
determined from retrospective review of inpatient and outpatient medical
records. Group II patients undergoing TEVAR underwent serial computed
tomographic imaging at 1 month, 6 months, and then yearly thereafter to
screen for the presence of endoleaks and ensure appropriate aneurysmal
regression. The last follow-up date for the purposes of this study was July
1, 2009.
Statistical Analysis
Comparisons between groups of preoperative, intraoperative, and post-
operative variables were performed with Fisher’s exact tests (2-sided) for
categoric variables and independent t tests (2-sided) for continuous vari-
ables. Continuous variables are reported as a mean  SD. Statistical analy-
ses were performed with SPSS version 17.0 software (SPSS Inc, Chicago,
Ill).RESULTS
Table 1 depicts the preoperative characteristics of the
patient groups. The patient groups were of similar composi-
tion in terms of mean age and comorbidities. One third of the
patients in each group had previously undergone sternot-
omy. There was a trend toward a higher rate of aortic dissec-
tion in group I (64% vs 33%, P ¼ .14).
Table 2 shows the intraoperative characteristics of groups
I and II. Forty-six percent of group I and 56% of group II
underwent some concomitant cardiac procedures
(P ¼ .71). Eighteen of group I patients and 44% of group
II patients underwent concomitant valve-sparing aortic
root replacement (P ¼ .18).
The hybrid arch repair permitted us to eliminate com-
pletely the use of HCA in group II, whereas conventional
open repair in group I required HCA in 82% of patients
(P<.0001). The 5 patients in group I who had the procedure
done exclusively with SACP had favorable anatomy amena-
ble to such an approach (bovine arch with the left carotid
artery origin off of the innominate trunk). There was also
a significantly shorter duration of SACP required in group
II than in group I (18.9  9.2 minutes vs 33.3  13.7
minutes, P ¼ .007), as well as shorter CPB (152  41.5rdiovascular Surgery c Volume 139, Number 3 719
TABLE 2. Intraoperative study group characteristics
Group I
(n ¼ 28)
Group II
(n ¼ 9) P value
Concomitant procedure (No.) 13 (46%) 5 (56%) .71
Valve-sparing procedure* (No.) 5 (18%) 4 (44%) .18
Axillary cannulation (No.) 27 (96%) 9 (100%) >.999
Use of HCA (No.) 23 (82%) 0 (0%) <.001
HCA time (min, mean  SD) 23.3  12.8 0  0 .004
Use of SACP (No.) 24 (86%) 9 (100%) >.999
SACP time (min, mean  SD) 33.3  13.7 18.9  9.2 .007
Cardiopulmonary bypass
time (min, mean  SD)
218.0  66.7 152.0  41.5 .009
Aortic crossclamp
time (min, mean  SD)
108.5  32.0 80.4  43.1 .043
Packed red blood
cells (units, mean  SD)
3.5  3.7 4.1  2.1 .64
Fisher’s Exact Test (2-sided) was used for categoric variables and independent t test
(2-sided) was used for continuous variables. HCA, Hypothermic circulatory arrest;
SACP, selective antegrade cerebral perfusion. *Valve-sparing procedures were defined
as a David procedure or an ascending aortic replacement with concomitant aortic valve
repair.
TABLE 3. Postoperative study group characteristics
Group I
(n ¼ 28)
Group II
(n ¼ 9) P value
Intensive care
unit stay (d, mean  SD)
11.1  18.9 6.4  6.4 .48
Hospital stay
(d, mean  SD)
17.9  20.3 14.8  9.6 .66
Neurologic complications*
(No.)
4 (14%) 0 (0%) .55
Death (No.) 5 (18%) 1 (11%) >.999
Fisher’s Exact Test (2-sided) was used for categoric variables and independent t test
(2-sided) was used for continuous variables. *Neurologic complications were defined
as a stroke or signs or symptoms of spinal cord ischemia.
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Sminutes vs 218  66.7 minutes, P ¼ .009) and aortic cross-
clamp (80.4  43.1 minutes vs 108.5  32.0 minutes,
P ¼ .043) times (Figure 3).
There were no significant differences between groups I
and II with regard to postoperative outcomes (Table 3).
There were no neurologic complications, defined as stroke
or signs or symptoms of spinal cord ischemia, in the hybrid
group. In the conventional group, 11% of patients had
stroke occur, and 7% of patients had spinal cord ischemia,
for a total neurologic complication rate of 14% (1 patient
had both complications). This difference did not achieve sta-
tistical significance. Technical success was achieved in
100% of cases in the hybrid group with concomitant or
staged TEVAR. There have been no endoleaks in the group
II patients, who have been followed up for a mean of 7.4 
5.5 months. The 30-day and in-hospital mortalities for groupFIGURE 3. Group II had significantly shorter selective antegrade cerebral
perfusion (SACP), cardiopulmonary bypass (CPB), and aortic crossclamp
times than did group I.
720 The Journal of Thoracic and Cardiovascular SurgI patients were 11% and 18%, respectively, compared with
11% and 11% for group II patients (P ¼ .54, P ¼ .76).
DISCUSSION
There have been consistent improvements in the operative
strategies used to address aortic arch and proximal descend-
ing aortic aneurysm and dissection repairs,7,8 but the perio-
perative morbidity and mortality associated with
conventional 1- or 2-stage procedures remain high.1 The
mortality risks have been reported as 5% for the first-stage
operation, 4% for the intervening interval, and 6% for the
second-stage repair.1 The risks of neurologic complications
related to HCA and extensive SACP times also remain a sub-
stantial burden in conventional TAAR. As a result, less inva-
sive means of completing the TAAR have been sought with
the use of thoracic aortic endografting.3-6,9 Such an approach
may shorten the interval required for recovery before the
second-stage intervention and lessen the risks inherent in
the delay until final repair. Still, completion rates with hybrid
strategies remain less than optimal, with 1 study reporting
a rate of 78% with a second-stage TEVAR approach.10
We have introduced a hybrid approach to TAAR that uses
left CSB and an open subtotal aortic arch replacement with
either concomitant or staged thoracic stent grafting to
achieve a hybrid TAAR with relatively short periods of
SACP and without the use of HCA. This approach appears
to be both feasible and safe through short-term follow-up
and avoids the need for a second open surgical procedure,
which is conventionally required with ‘‘elephant trunk’’
repairs of the aortic arch and descending aorta. The aortic
graft serves as a relatively long proximal landing zone that
makes the TEVAR procedure relatively straightforward
and reproducible, minimizing the risks of incomplete arch
repairs. In our small series, this approach was associated
with significant decreases in the duration of SACP, CPB,
and aortic crossclamping, and it eliminated the need for
HCA relative to open conventional TAAR.
This hybrid approach is fully compatible with root recon-
structions and valve-sparing root replacements. In addition,
33% of our hybrid series were for ascending or arch dissec-
tions, meaning that the technique will be applicable toery c March 2010
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Semergency operations once the approach has been standard-
ized. Although we did not find a statistically significant de-
crease in neurologic complications, the avoidance of HCA
and the relatively short SACP times imply that protective
benefits might be seen in larger series. Future multicenter
studies will evaluate this potential.
Several benefits are conferred by the left CSB as part of
this technique. These include the avoidance of the left sub-
clavian artery–graft anastomosis through a sternotomy,
which is usually technically challenging and unduly pro-
longs HCA. In addition, left CSB allows flow from the left
subclavian to left carotid artery during the left carotid artery–
graft anastomosis, meaning that neither HCA nor SACP is
required for this interval. Left CSB also allows the graft–
distal aorta anastomosis to be performed between the left
carotid and left subclavian takeoff and therefore more prox-
imally than in conventional arch repairs (after the takeoff of
the left subclavian artery). This typically means that the dis-
tal anastomosis is performed with better visualization and
relative ease, minimizing the SACP time required. The left
subclavian artery is ligated at the end of the open procedure,
and the distal aortic graft serves merely as the proximal land-
ing zone for the TEVAR, so it is not as important as with
conventional repairs that its location be as distal as possible.
We prefer to ligate the left subclavian artery during the
open procedure, as opposed to occluding it later at the
time of stent graft placement (eg, with coil or Amplatzer de-
vice embolization). We believe that flow into the left subcla-
vian artery from its native origin could compete with flow
from the CSB in the interim between the open and endovas-
cular stages of the repair. This could hypothetically lead to
stasis of blood in the CSB graft and increase the risk of graft
thrombosis. For open procedures with concomitant stent
grafting, we believe that it is more feasible to ligate the
left subclavian artery with an endovascular stapler through
the sternotomy than to access the left brachial artery for en-
dovascular ligation.
The optimal timing of the TEVAR in relation to the open
portion of hybrid arch reconstructions still remains to be deter-
mined, and single-stage and dual-stage interventions have
been reported.10,11 The advantages of a concomitant proce-
dure are the avoidance of transfemoral arterial access and of
the staging of the procedure. Such an approach is simplified
with the use of a custom graft with an additional side arm ame-
nable to the antegrade deployment of a thoracic endograft.
The disadvantages include the necessity of a hybrid operating
room (or at least an operating room with a high-resolution
C-arm for intraoperative fluoroscopy) and the potential for
prolonging the operative time of a complex, open procedure.
If the TEVAR is to be staged and performed by a transfemoral
approach, radiopaque markers and the long proximal landing
zone (within the aortic graft) that is of known size do make this
quite feasible for performance during the same patient admis-
sion. This is witnessed by our 100% technical success rate ofThe Journal of Thoracic and CaTEVAR in our group II patients, with no endoleaks through
a mean follow-up of 7 months.
The limitations of our study include all the caveats of
a small, non-randomized, retrospective study with limited
follow-up. The power of our series to detect differences in
neurologic outcomes was low, not surprisingly as this was
a feasibility study aiming to introduce and refine our surgical
technique. Because of the extensive morbidity and mortality
associated with conventional open approaches, however, we
have currently abandoned open approaches and moved to
our described hybrid TAAR technique for all cases of
TAAR, with the exception of patients with connective tissue
disorders. All patients (but particularly younger patients) are
counseled preoperatively concerning the need for long-term
imaging surveillance with the hybrid approach and that the
long-term durability of endovascular stent grafts used in
this regard remain unproven. The durability of TEVAR
will be evaluated with future studies comparing the long-
term outcomes of conventional and hybrid arch repairs.
All these patients will require serial imaging and close pa-
tient follow-up to ensure appropriate aneurysm regression
and exclusion. Additional follow-up is needed, and future
studies will include standardized definitions for neurologic
complications and other adverse events, as well as additional
outcome measures (eg, patient satisfaction, quality of life,
neurocognitive assessment, and cost). The integration of TE-
VAR into TAAR remains an experimental approach, be-
cause thoracic stent grafts such as the GORE-TAG device
have not received formal approval for this purpose.
In summary, left CSB before an open subtotal aortic arch
replacement with concomitant or staged thoracic stent graft-
ing to achieve hybrid TAAR was associated with decreases
in SACP, CPB, and aortic crossclamp times and eliminated
the need for HCA. This technique may decrease the risk of
neurologic complications associated with TAAR and pro-
vide a viable hybrid approach to patients with aortic arch an-
eurysms and dissections.References
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Dr JohnA.Kern (Charlottesville, Va). Dr Xydas, I congratulate
you on a nice presentation and study. Looking back at your last
330-odd aortic patients, as you point out, 37 underwent TAAR
procedures with good results. With the advent of endovascular
technology, your group, like many groups, is getting creative in
ways to minimize circulatory arrest times, minimize cerebral
malperfusion times, and improve outcomes, and certainly with
this study and this small group of patients you have done that.
You have certainly demonstrated decreased CPB, crossclamp,
and circulatory arrest times. I really have just a few questions,
some of which are technical. Tell me about the CSB. Did you
always do that concomitantly with the arch procedure, or did you
do that a day or so before? In addition to that, because it appears
that it is routine, because you are using the CSB to maintain carotid
perfusion, did you necessarily image the head to define the cerebro-
vascular anatomy?
Dr Xydas. We do the left CSB in the same setting and start off
our procedure with it in the operating room. The rationale for this is
that potentially if it was done earlier, even over the weekend or
a couple of days, graft patency might be diminished if there was
competitive flow. In terms of the rationale for doing the left CSB,
it is really 2-fold. One reason is in doing the carotid anastomosis
through the sternotomy, it allows us protection with the subcla-
vian–carotid flow during that span. So the anatomy is not necessar-
ily something to which we have to react. We did not do any cerebral
imaging other than the standard preoperative computed tomo-
graphic angiography. The second reason for doing the bypass is
that it eliminates the need for doing the subclavian–graft anastomo-
sis in the chest, which is typically difficult in a deep hole with
imperfect visualization.
Dr Kern. Your mean follow-up time naturally was around
7 months, as you point out, and I imagine most of these patients
are older. Certainly the CSB is the easier operation. This is almost
a complete TAAR, so I really congratulate you on avoiding the arch
debranching procedures, which establish blood flow to the great
vessels through a smaller graft coming off the ascending aorta. I
think the durability of this procedure is going to be quite good;
however, with the CSB over time, you can’t be sure. In the TEVAR722 The Journal of Thoracic and Cardiovascular Surggroup, the second group, you have done the endograft both simul-
taneously and staged in that small group, is that right?
Dr Xydas. Yes, this is correct.
Dr Kern. Do you have any preferences, do you have anything
you can tell us about when you prefer to do it at the same time
versus when you stage it?
Dr Xydas. This issue requires ongoing work, and there are no
clear winners in terms of how to approach this. We did this partly
on clinical grounds but also on administrative grounds in terms of
whether the hybrid room was available for doing the procedure
concomitantly versus in a staged manner. If there was an extensive
concomitant procedure expected, however, we did opt to do it in
a staged approach. Only 2 of 9 patients underwent the procedure
concomitantly, with the other 7 undergoing it in a staged fashion.
Again, however, I think that only future research in this area will
enlighten us as to which approach is going to be better. It was
interesting at this meeting to hear from Dr Griepp’s group, which
presented data suggesting that performing it in a staged fashion
past 5 to 7 days may decrease the incidence of spinal cord ische-
mia or other neurologic issues. In terms of the patency of the left
CSB, once you are in the postoperative phase, our expectation is
that even if the patency rates of these grafts are low, this is not go-
ing to affect the patients neurologically in that many patients un-
dergoing TEVAR actually have their left subclavian artery
occluded and covered with the TEVAR without a bypass and
seem to do relatively well. Staging it enough to allow collaterali-
zation to some degree will probably diminish even further the
effect of left carotid–subclavian graft patency on long-term
neurologic outcome.
Dr Kern. For those couple of patients who underwent concom-
itant stent grafting, did you use a lumbar drain? Did they undergo
extensive enough stent grafting that you used a lumbar drain?
Dr Xydas. The patients who underwent concomitant procedures
had a lumbar drain. Patients who underwent the staged procedure
also had lumbar drains routinely, even if they didn’t require exten-
sive stenting across the descending aorta.
Dr Joseph E. Bavaria (Philadelphia, Pa). Do you coil out your
left subclavian at the end?
Dr Xydas. We do occlude the proximal left subclavian artery at
the end of the procedure. If it is easy to approach through the ster-
notomy, we either staple it or ligate it. If not, we approach it endo-
vascularly at the time of the TEVAR through a staged approach.
Dr Bavaria. Also, you can’t put a large GORE graft through an
8-mm graft. So are you using small grafts? We usually use a 10-mm
side arm.
DrXydas.We are actually using a 9-mm side branch on our cus-
tom aortic grafts for use with concomitant TEVAR procedures with
both small and large stent grafts.
Dr Lars G. Svensson (Cleveland, Ohio). Thank you, Dr Xydas.
This is an interesting field, and maybe some people should get
together and do a multicenter study on this, because there are
a lot of evolving issues here, as you brought up.
Dr Xydas. Thank you.ery c March 2010
